From basics to clinical: a comprehensive review on spinal cord injury

dc.commentshttp://www.3bs.uminho.pt/node/17906por
dc.contributor.authorSilva, N. A.
dc.contributor.authorSousa, Nuno
dc.contributor.authorReis, R. L.
dc.contributor.authorSalgado, A. J.
dc.date.accessioned2014-03-03T11:59:41Z
dc.date.available2014-03-03T11:59:41Z
dc.date.issued2014
dc.date.submitted2014-02
dc.date.updated2014-02-27T16:36:25Z
dc.description.abstractSpinal cord injury (SCI) is a devastating neurological disorder that affects thousands of individuals each year. Over the past decades an enormous progress has been made in our understanding of the molecular and cellular events generated by SCI, providing insights into crucial mechanisms that contribute to tissue damage and regenerative failure of injured neurons. Current treatment options for SCI include the use of high dose methylprednisolone, surgical interventions to stabilize and decompress the spinal cord, and rehabilitative care. Nonetheless, SCI is still a harmful condition for which there is yet no cure. Cellular, molecular, rehabilitative training and combinatorial therapies have shown promising results in animal models. Nevertheless, work remains to be done to ascertain whether any of these therapies can safely improve patient's condition after human SCI. This review provides an extensive overview of SCI research, as well as its clinical component. It starts covering areas from physiology and anatomy of the spinal cord, neuropathology of the SCI, current clinical options, neuronal plasticity after SCI, animal models and techniques to assess recovery, focusing the subsequent discussion on a variety of promising neuroprotective, cell-based and combinatorial therapeutic approaches that have recently moved, or are close, to clinical testing.por
dc.description.sponsorshipThe authors would like to acknowledge the Portuguese Foundation for Science and Technology (grant no. PTDC/SAU-BMA/114059/2009; pre-doctoral fellowship to Nuno Silva - SFRH/BD/40684/2007); the Foundation Calouste de Gulbenkian for funds attributed to A.J. Salgado under the scope of the Gulbenkian Program to Support Research in the Life Sciences; co-funded by Programa Operacional Regional do Norte (ON.2-0 Novo Norte), ao abrigo do Quadro de Referencia Estrategico Nacional (QREN), atraves do Fundo Europeu de Desenvolvimento Regional (FEDER).por
dc.distributioninternationalpor
dc.identifier.doi10.1016/j.pneurobio.2013.11.002
dc.identifier.issn0301-0082por
dc.identifier.pmid24269804por
dc.identifier.urihttps://hdl.handle.net/1822/28200
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherElsevierpor
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S0301008213001196por
dc.rightsrestrictedAccesspor
dc.subjectCell therapypor
dc.subjectClinical trialspor
dc.subjectCombinatorial therapiespor
dc.subjectMolecular therapypor
dc.subjectPathophysiologypor
dc.subjectSpinal cord injurypor
dc.subject.wosScience & Technologypor
dc.titleFrom basics to clinical: a comprehensive review on spinal cord injurypor
dc.typearticle
dspace.entity.typePublicationen
oaire.citationEndPage57por
oaire.citationStartPage25por
oaire.citationTitleProgress in Neurobiologypor
oaire.citationVolume114por
sdum.journalProgress in Neurobiologypor
sdum.publicationstatuspublishedpor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
17906-NASilva-Progress in Neurobiology 2014.pdf
Tamanho:
3.1 MB
Formato:
Adobe Portable Document Format